Akihiko Numata

2.3k citations
87 papers · 1.8k indexed · h-index 23
Topics
Hematopoietic Stem Cell Transplantation (16 papers)Cytokine Signaling Pathways and Interactions (11 papers)Immune Response and Inflammation (10 papers)

In The Last Decade

Akihiko Numata

80 papers receiving 1.7k citations

Peers

Akihiko Numata
Comparison fields: 5 of 110
  • Immunology 607
  • Oncology 476
  • Molecular Biology 432
  • Hematology 255
  • Epidemiology 219
Replace Atsushi Togawa with:
Atsushi Togawa Japan
Chihiro Terai Japan
Henny G. Otten Netherlands
K Wonigeit Germany
Ajda T. Rowshani Netherlands
Zaher A. Radi United States
I. C. M. Maclennan United Kingdom
Stavros Rafail United States
Roberta Bulla Italy
Federico Perosa Italy
Akihiko Numata relative to Atsushi Togawa Japan Atsushi Togawa's profile →
Citations per field
00.5×1.7×
Atsushi Togawa · 1×
Citations per year

Countries citing papers authored by Akihiko Numata

Since Specialization
Citations

This map shows the geographic impact of Akihiko Numata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Numata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Numata more than expected).

Fields of papers citing papers by Akihiko Numata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Numata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Numata. The network helps show where Akihiko Numata may publish in the future.

Co-authorship network of co-authors of Akihiko Numata

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Numata. A scholar is included among the top collaborators of Akihiko Numata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Numata. Akihiko Numata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 21
3 7
4 18
5 54
6 2
7 5
8 31
9 2
10 24
11 2
12 12
13 10
14 27
15 12
16 52
17 57
18 7
19 2
20 260

About Akihiko Numata

Akihiko Numata is a scholar working on Hematology, Nephrology and Immunology, having authored 87 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Cytokine Signaling Pathways and Interactions (11 papers) and Immune Response and Inflammation (10 papers). The work is most often cited by research in Nephrology (206 citations), Immunology (607 citations) and Hematology (255 citations). Akihiko Numata has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Akio Nakane, Tomonori Minagawa, Kazuya Shimoda, Ken Takase, Hisashi Gondo, Tadashi Matsuda, Mine Harada, Toshihiro Miyamoto, Kenichi Aoki and Kouji Kato. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026